(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-4-METHYLPENTANOATE
Compound with spectra: 1 NMR
![(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-4-METHYLPENTANOATE](/api/compound/JlNiKtI0BEO.png?ph=true&h=300&w=458 "(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-4-METHYLPENTANOATE")
| SpectraBase Compound ID | JlNiKtI0BEO |
|---|---|
| InChI | InChI=1S/C13H18FN3O5/c1-7(2)4-9(12(20)22-3)15-10(18)6-17-5-8(14)11(19)16-13(17)21/h5,7,9H,4,6H2,1-3H3,(H,15,18)(H,16,19,21)/t9-/m0/s1 |
| InChIKey | VNTKWKRACHJIRF-VIFPVBQESA-N |
| Mol Weight | 315.3 g/mol |
| Molecular Formula | C13H18FN3O5 |
| Exact Mass | 315.123049 g/mol |
| Enantiomer InChIKey | VNTKWKRACHJIRF-SECBINFHSA-N |
| Racemate InChIKey | VNTKWKRACHJIRF-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(R)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-4-(METHYLTHIO)-BUTANOATE
(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE
(2S,3S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-HYDROXYBUTANOATE
(R)-ETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE
1-[(1',4',5',6'-Tetrahydro-4'-ethyl-2'-pyrimidinyl)methyl]-thymine - hydrochloride
1-[(1',4',5',6'-Tetrahydro-5',5'-dimethyl-2'-pyrimidinyl)methyl]-thymine - hydrochloride
1-[(4',5'-Dihydro-4',4'-dimethyl-3H-imidazol-2'-yl)methyl]-thymine - hydrochloride
1 -(3 -(4 -Aminobenzenesulfonamido) -3 -oxopropyl) -5 -fluoropyrimidine-2,4 -dione
2-ACETYL-2H-INDAZOLE-L-GLYCYL-L-LEUCINE-METHYLESTER
(5-fluoro-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)methyl 1-adamantanecarboxylate
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil | Molecules | 2009 |